Skip to main content

Market Overview

Recap: Abbott Laboratories Q2 Earnings


Shares of Abbott Laboratories (NYSE:ABT) rise 1.7% in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were down 30.49% over the past year to $0.57, which beat the estimate of $0.41.

Revenue of $7,328,000,000 decreased by 8.16% year over year, which beat the estimate of $6,750,000,000.

Looking Ahead

For 2020, the company expects adjusted earnings of "at least" $3.25 per share.

How To Listen To The Conference Call

Date: Jul 16, 2020

Time: 09:30 AM

ET Webcast URL:

Price Action

52-week high: $100.00

Company's 52-week low was at $61.61

Price action over last quarter: down 0.04%

Company Profile

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.


Related Articles (ABT)

View Comments and Join the Discussion!

Posted-In: Earnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at